| Dr Stephanie Ann Branam, DO | |
|
844 Washington Ave Ste 1200, Holland, MI 49423-7186 | |
| (616) 393-5336 | |
| (616) 392-2889 |
| Full Name | Dr Stephanie Ann Branam |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 12 Years |
| Location | 844 Washington Ave Ste 1200, Holland, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750642831 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 5101020011 (Michigan) | Primary |
| 207R00000X | Internal Medicine | 5101020011 (Michigan) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Holland Community Hospital | Holland, MI | Hospital |
| Mercy Health Hackley Campus | Muskegon, MI | Hospital |
| Spectrum Health | Grand rapids, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Holland Community Hospital | 0446157291 | 142 |
News Archive
Wading into the incendiary subject of birth control for young teenagers, the American Academy of Pediatrics (AAP) on Monday called on the nation's pediatricians to counsel all of their adolescent patients about emergency contraception and make advance prescriptions for it available to girls under 17.
A new University of Missouri study shows that the exposure to the controversial chemical Bisphenol A (BPA) through diet has been underestimated by previous lab tests.
A bill that would allow state officials to reject rate increases proposed by health insurers is under intense lobbying pressure as it faces a key committee vote this week. Groups representing insurers, doctors and hospitals are trying to have the California bill weakened or killed, although for different reasons.
AFFiRiS AG will focus its Alzheimer's vaccine program on one product candidate at an unexpectedly early stage of development: the vaccine candidate AD02 is planned to enter into Phase II clinical trial early in 2010. This decision by the company immediately follows the completion of two Phase I trials with the candidates AD01 and AD02. The company based its fast decision on the first interim analysis of the secondary endpoints at the six month time point.
A recent Brazilian study demonstrates that hyperimmune globulin formulations generated against the recombinant spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provide significantly high antibody titer with highly neutralizing capacity. The study is currently available on the bioRxiv preprint server.
› Verified 7 days ago
| Entity Name | Holland Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780888099 PECOS PAC ID: 0446157291 Enrollment ID: O20031218000484 |
News Archive
Wading into the incendiary subject of birth control for young teenagers, the American Academy of Pediatrics (AAP) on Monday called on the nation's pediatricians to counsel all of their adolescent patients about emergency contraception and make advance prescriptions for it available to girls under 17.
A new University of Missouri study shows that the exposure to the controversial chemical Bisphenol A (BPA) through diet has been underestimated by previous lab tests.
A bill that would allow state officials to reject rate increases proposed by health insurers is under intense lobbying pressure as it faces a key committee vote this week. Groups representing insurers, doctors and hospitals are trying to have the California bill weakened or killed, although for different reasons.
AFFiRiS AG will focus its Alzheimer's vaccine program on one product candidate at an unexpectedly early stage of development: the vaccine candidate AD02 is planned to enter into Phase II clinical trial early in 2010. This decision by the company immediately follows the completion of two Phase I trials with the candidates AD01 and AD02. The company based its fast decision on the first interim analysis of the secondary endpoints at the six month time point.
A recent Brazilian study demonstrates that hyperimmune globulin formulations generated against the recombinant spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provide significantly high antibody titer with highly neutralizing capacity. The study is currently available on the bioRxiv preprint server.
› Verified 7 days ago
| Entity Name | Sparrow Specialty Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437655842 PECOS PAC ID: 2466347638 Enrollment ID: O20180607002998 |
News Archive
Wading into the incendiary subject of birth control for young teenagers, the American Academy of Pediatrics (AAP) on Monday called on the nation's pediatricians to counsel all of their adolescent patients about emergency contraception and make advance prescriptions for it available to girls under 17.
A new University of Missouri study shows that the exposure to the controversial chemical Bisphenol A (BPA) through diet has been underestimated by previous lab tests.
A bill that would allow state officials to reject rate increases proposed by health insurers is under intense lobbying pressure as it faces a key committee vote this week. Groups representing insurers, doctors and hospitals are trying to have the California bill weakened or killed, although for different reasons.
AFFiRiS AG will focus its Alzheimer's vaccine program on one product candidate at an unexpectedly early stage of development: the vaccine candidate AD02 is planned to enter into Phase II clinical trial early in 2010. This decision by the company immediately follows the completion of two Phase I trials with the candidates AD01 and AD02. The company based its fast decision on the first interim analysis of the secondary endpoints at the six month time point.
A recent Brazilian study demonstrates that hyperimmune globulin formulations generated against the recombinant spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provide significantly high antibody titer with highly neutralizing capacity. The study is currently available on the bioRxiv preprint server.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephanie Ann Branam, DO 844 Washington Ave Ste 1200, Holland, MI 49423-7186 Ph: (616) 393-5336 | Dr Stephanie Ann Branam, DO 844 Washington Ave Ste 1200, Holland, MI 49423-7186 Ph: (616) 393-5336 |
News Archive
Wading into the incendiary subject of birth control for young teenagers, the American Academy of Pediatrics (AAP) on Monday called on the nation's pediatricians to counsel all of their adolescent patients about emergency contraception and make advance prescriptions for it available to girls under 17.
A new University of Missouri study shows that the exposure to the controversial chemical Bisphenol A (BPA) through diet has been underestimated by previous lab tests.
A bill that would allow state officials to reject rate increases proposed by health insurers is under intense lobbying pressure as it faces a key committee vote this week. Groups representing insurers, doctors and hospitals are trying to have the California bill weakened or killed, although for different reasons.
AFFiRiS AG will focus its Alzheimer's vaccine program on one product candidate at an unexpectedly early stage of development: the vaccine candidate AD02 is planned to enter into Phase II clinical trial early in 2010. This decision by the company immediately follows the completion of two Phase I trials with the candidates AD01 and AD02. The company based its fast decision on the first interim analysis of the secondary endpoints at the six month time point.
A recent Brazilian study demonstrates that hyperimmune globulin formulations generated against the recombinant spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provide significantly high antibody titer with highly neutralizing capacity. The study is currently available on the bioRxiv preprint server.
› Verified 7 days ago
Dr. Marcel Michael Letourneau, D.O Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 602 Michigan Ave Ste 102, Holland, MI 49423 Phone: 616-494-8724 | |
Tricia R Miller, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 437 North 120th Ave, Holland, MI 49424 Phone: 616-738-0737 | |
Timothy Conlon, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3235 N Wellness Dr, Building A Suite 120b, Holland, MI 49424 Phone: 616-399-9522 | |
Dr. Karl Nadolsky Jr., DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 904 Washington Ave Ste 210, Holland, MI 49423 Phone: 616-395-2833 | |
Brian Drozdowski, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 437 120th Ave, Holland, MI 49424 Phone: 616-738-0737 | |
Dr. Daniel Peshka, DO Rheumatology Medicare: Medicare Enrolled Practice Location: 143 Sunrise Dr, Holland, MI 49423 Phone: 616-402-3994 | |
Matthew Steinberger, M.D Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 602 Michigan Ave, Holland, MI 49423 Phone: 616-546-4950 Fax: 616-546-4955 |